Amarin Stock News

An activist investor revealed that it held a small stake in the company.

Related Stocks: KNTE , CNTA , TYRA , TNGX , BPMC , FULC , TPTX , IOVA , SGEN , AMRN , RACA , KDMN , AGEN , BMRN ,

An activist investor revealed that it held a small stake in the company.

Amarin Corporation plc (NASDAQ: AMRN ) reported new data for Vascepa/Vazkepa (icosapent ethyl) at the American Heart Association (AHA) Scientific Sessions. The investigators concluded that "Icosapent ethyl 4 g/day significantly reduced total (first and subsequent) primary endpoints by 32%, and trended toward Full story available on Benzinga.com

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis Treatment Candidate Keza

Amarin Corporation plc (NASDAQ: AMRN) reported new data for Vascepa/Vazkepa (icosapent ethyl) at the American Heart Association (AHA) Scientific Sessions. The investigators concluded that "Icosapen

VASCEPA/VAZKEPA found in prespecified and post hoc analyses to reduce total ischemic events by 32% in patients with prior PAD DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that data adding to the growing body of

VASCEPA/VAZKEPA found in prespecified and post hoc analyses to reduce total ischemic events by 32% in patients with prior PAD VASCEPA/VAZKEPA found in prespecified and post hoc analyses to reduce tota

Hayek Kallen Investment Management boosted its position in shares of Amarin Co. plc (NASDAQ:AMRN) by 3.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 161,952 shares of the biopharmaceutical companys stock after purchasing an additional 5,541 shares during the period. Hayek Kallen Investment Managements []

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences. Among the

Stifel Financial Corp reduced its stake in shares of Amarin Co. plc (NASDAQ:AMRN) by 11.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,944 shares of the biopharmaceutical companys stock after selling 3,135 shares during the quarter. Stifel []

Amarin Corporation plc (AMRN) CEO Karim Mikhail on Q3 2021 Results - Earnings Call Transcript

Amarin's (AMRN) reports lower sales volume for its drug, Vascepa, in the United States during the third quarter. The company's stock falls in pre-market trading.

DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company will host a conference call with members of Amarin's seni

Amarin Corporation plc (AMRN) Management Presents at Cantor Fitzgerald Global Healthcare 2021 Conference (Transcript)